Cargando…

MicroRNA dysregulation in multiple sclerosis

Multiple sclerosis (MS) is a chronic inflammatory disease characterized by central nervous system (CNS) demyelination and axonal degeneration. Although the cause of MS is still unknown, it is widely accepted that novel drug targets need to focus on both decreasing inflammation and promoting CNS repa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jr, Omar de Faria, Moore, Craig S., Kennedy, Timothy E., Antel, Jack P., Bar-Or, Amit, Dhaunchak, Ajit S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2013
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551282/ https://www.ncbi.nlm.nih.gov/pubmed/23346094 http://dx.doi.org/10.3389/fgene.2012.00311

Ejemplares similares

Erratum: microRNA dysregulation in multiple sclerosis
por: Moore, Craig S., et al.
Publicado: (2013)

Regulation of miRNA 219 and miRNA Clusters 338 and 17-92 in Oligodendrocytes
por: de Faria Jr., Omar, et al.
Publicado: (2012)

A Novel MicroRNA-132-Surtuin-1 Axis Underlies Aberrant B-cell Cytokine Regulation in Patients with Relapsing-Remitting Multiple Sclerosis
por: Miyazaki, Yusei, et al.
Publicado: (2014)

TMEM10 Promotes Oligodendrocyte Differentiation and is Expressed by Oligodendrocytes in Human Remyelinating Multiple Sclerosis Plaques
por: de Faria, Omar, et al.
Publicado: (2019)

Epigenetic alteration and microRNA dysregulation in cancer
por: Suzuki, Hiromu, et al.
Publicado: (2013)

Dysregulation of MicroRNA Regulatory Network in Lower Extremities Arterial Disease
por: Bogucka-Kocka, Anna, et al.
Publicado: (2019)

Post-Transcriptional Dysregulation of microRNA and Alternative Polyadenylation in Colorectal Cancer
por: Mao, Zhanrui, et al.
Publicado: (2020)

RNA Dysregulation in Amyotrophic Lateral Sclerosis
por: Butti, Zoe, et al.
Publicado: (2019)

Sequencing the immunopathologic heterogeneity in multiple sclerosis
por: Antel, Jack P, et al.
Publicado: (2015)

Dysregulated MicroRNA Involvement in Multiple Sclerosis by Induction of T Helper 17 Cell Differentiation
por: Chen, Chen, et al.
Publicado: (2018)

Dysregulation of MicroRNAs in Hypertrophy and Ossification of Ligamentum Flavum: New Advances, Challenges, and Potential Directions
por: Zhang, Baoliang, et al.
Publicado: (2021)

MicroRNAs: New Players in Multiple Myeloma
por: Pichiorri, Flavia, et al.
Publicado: (2011)

MicroRNA Dysregulation in Diabetic Ischemic Heart Failure Patients
por: Greco, Simona, et al.
Publicado: (2012)

Modulation of microRNA Activity by Semi-microRNAs
por: Plante, Isabelle, et al.
Publicado: (2012)

Dysregulation of CircRNA_0001946 Contributes to the Proliferation and Metastasis of Colorectal Cancer Cells by Targeting MicroRNA-135a-5p
por: Deng, Zhenwei, et al.
Publicado: (2020)

Seeking neuroprotection in multiple sclerosis: an ongoing challenge
por: Antel, Jack P., et al.
Publicado: (2023)

MicroRNAs as clinical biomarkers?
por: Angelini, Timothy G., et al.
Publicado: (2015)

MicroRNA and Long Non-coding RNA Regulation in Skeletal Muscle From Growth to Old Age Shows Striking Dysregulation of the Callipyge Locus
por: Mikovic, Jasmine, et al.
Publicado: (2018)

Analysis of common genetic variation across targets of microRNAs dysregulated both in ASD and epilepsy reveals negative correlation
por: Stella, Carol, et al.
Publicado: (2023)

Genetic variants in microRNA genes: impact on microRNA expression, function, and disease
por: Cammaerts, Sophia, et al.
Publicado: (2015)

Can microRNAs keep inflammasomes in check?
por: Qazi, Omar, et al.
Publicado: (2013)

Wide-Ranging Analysis of MicroRNA Profiles in Sporadic Amyotrophic Lateral Sclerosis Using Next-Generation Sequencing
por: De Felice, Bruna, et al.
Publicado: (2018)

Trophoblasts, invasion, and microRNA
por: Doridot, Ludivine, et al.
Publicado: (2013)

Fishing Into the MicroRNA Transcriptome
por: Herkenhoff, Marcos E., et al.
Publicado: (2018)

MicroRNA-21 and microRNA-148a affects PTEN, NO and ROS in canine leishmaniasis
por: De Freitas, Jéssica Henrique, et al.
Publicado: (2023)

MicroRNAs and Multiple Sclerosis
por: Tufekci, Kemal Ugur, et al.
Publicado: (2010)

Unraveling the Mystery of Cancer by Secretory microRNA: Horizontal microRNA Transfer between Living Cells
por: Kosaka, Nobuyoshi, et al.
Publicado: (2012)

Modeling Equilibrium of microRNA Expression
por: Chan, Lawrence W. C.
Publicado: (2011)

Pathogenic microRNA’s in myeloid malignancies
por: Khalaj, Mona, et al.
Publicado: (2014)

MicroRNA basis of physiological hypertrophy
por: Fu, Siyi, et al.
Publicado: (2013)

Predicting Gene Ontology Function of Human MicroRNAs by Integrating Multiple Networks
por: Deng, Lei, et al.
Publicado: (2019)

MicroRNAs Dysregulation and Metabolism in Multiple System Atrophy
por: Xiang, Chunchen, et al.
Publicado: (2019)

Environmental Influencers, MicroRNA, and Multiple Sclerosis
por: Mohammed, Eiman MA
Publicado: (2020)

Effects of fumarates on circulating and CNS myeloid cells in multiple sclerosis
por: Michell‐Robinson, Mackenzie A., et al.
Publicado: (2015)

MicroRNA Control of Invasion and Metastasis Pathways
por: Sreekumar, Rahul, et al.
Publicado: (2011)

Role of CTCF in the regulation of microRNA expression
por: Saito, Yoshimasa, et al.
Publicado: (2012)

Progress and challenge of microRNA research in immunity
por: Lee, Hyang-Mi, et al.
Publicado: (2014)

The MicroRNA Interaction Network of Lipid Diseases
por: Kandhro, Abdul H., et al.
Publicado: (2017)

The Potential for microRNA Therapeutics and Clinical Research
por: Hanna, Johora, et al.
Publicado: (2019)

Exosome-Derived microRNA: Efficacy in Cancer
por: Padda, Jaskamal, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ndp1t2aidohvufjj4i1ptfhb0l